LAWRENCE, Mass., Dec. 20 /PRNewswire-FirstCall/ -- NxStage Medical, Inc. , announced plans to release its financial results for the fourth quarter and year ended December 31, 2005 on Thursday, February 2, 2006 before the open of the U.S. financial markets.
NxStage will also host a conference call at 9:00 a.m. EST on February 2, 2006 to discuss the fourth quarter and year-end 2005 results. To listen to the conference call, please dial (866) 825-3308 for domestic callers and (617) 213-8062 for international callers. The passcode is 31550920. A replay of the conference call will be available through February 9, 2006 by dialing 888-286- 8010 (domestic) and 617-801-6888 (international), passcode 43928800. An online archive of the conference call will also be available by accessing the Investor Relations section of the company's website at http://www.nxstage.com.
About NxStage Medical
NxStage Medical, Inc. is a medical device company, headquartered in Lawrence, Massachusetts, USA, that develops, manufactures and markets innovative systems for the treatment of end-stage renal disease, or ESRD, and acute kidney failure. For more information on NxStage and its products, please visit the company's website at http://www.nxstage.com.
Forward-Looking Statements
This release contains "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. All statements contained in this release that are not clearly historical in nature are forward-looking, and the words "anticipate," "believe," "expect," "estimate," "plan," and similar expressions are generally intended to identify forward- looking statements. The forward-looking statements in this release include NxStage's plan to release its financial results on February 2, 2006. Actual results may differ materially from those indicated by these forward-looking statements as a result of various important factors including, but not limited to, unexpected difficulty in closing the company's financial books for the quarter and other factors that are discussed in NxStage's Quarterly Report on Form 10-Q for the quarter ended September 30, 2005 filed with the SEC. NxStage is under no obligation to (and expressly disclaims any such obligation to) update or alter its forward-looking statements, whether as a result of new information, future events or otherwise.
Contact David N. Gill Senior Vice President & Chief Financial Officer 978-687-4700
NxStage Medical, Inc.CONTACT: David N. Gill, Senior Vice President & Chief Financial Officer ofNxStage Medical, Inc., +1-978-687-4700
